Healthbeat reports that spring break travel raises concerns about measles spread in the U.S., with over 1,300 cases already ...
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, today announced the annual results for 2025 as of December 13, 2025. 2025 ...
First new FDA-approved treatment option in nearly 20 years for families living with this rare lysosomal storage disease; First FDA-approved medicine in emerging new class of bioth ...
The antibody shots are about 80% effective at preventing babies from ending up in intensive care because of RSV. The ...
DifGen Pharmaceuticals and Aveva Drug Delivery Systems today announced a strategic platform collaboration with Biostax Corp d/b/a Attune Biotech, SGP Holdings, and Callan JMB to lead U.S.-based ...
Upadacitinib is efficacious as induction and maintenance therapy for refractory pediatric ulcerative colitis and IBD-U.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results